glucagen hypokit 1 mg powder and solvent for solution for injection
novo nordisk a/s - glucagon - powder and solvent for solution for injection - 1 milligram(s) - glycogenolytic hormones; glucagon
glucagen for injection 1 mgml
novo nordisk pharma (singapore) pte ltd - glucagon (as hydrochloride) - injection, powder, for solution - 1mg/ml - glucagon (as hydrochloride) 1mg/ml
glucagen hypokit 1 mg
novo nordisk ltd., israel - glucagon as hydrochloride - powder and solvent for solution for injection - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.
glucagen hypokit 1mg powder and solvent for solution for injection in pre-filled syringe
novonordisk a/s novo alle, dk – 2880 bagsvaerd, denmark - glucagon - powder and solvent for solution for injection - glucagon - pancreatic hormones
glucagen 1mg powder and solvent for solution for injection
novonordisk a/s novo alle, dk – 2880 bagsvaerd, denmark - glucagon - powder and solvent for solution for injection - glucagon - pancreatic hormones
glucagen kit
novo nordisk canada inc - glucagon (recombinant dna origin) (glucagon hydrochloride) - kit - 1mg - glucagon (recombinant dna origin) (glucagon hydrochloride) 1mg - glycogenolytic agents
glucagen hypokit
novo nordisk canada inc - glucagon (recombinant dna origin) (glucagon hydrochloride) - kit - 1mg - glucagon (recombinant dna origin) (glucagon hydrochloride) 1mg - glycogenolytic agents
glucagen hypokit 1mg powder and solvent for solution for injection
novo nordisk ltd - glucagon hydrochloride - powder and solvent for solution for injection - 1mg
baqsimi
eli lilly nederland b.v. - glucagon - diabetes mellitus - pancreatic hormones, glycogenolytic hormones - baqsimi is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 4 years and over with diabetes mellitus.
ogluo
tetris pharma b.v - glucagon - diabetes mellitus - pancreatic hormones, glycogenolytic hormones - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.